Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia

Alex V. Postma, Isabelle Denjoy, Theo M. Hoorntje, Jean-Marc Lupoglazoff, Antoine Da Costa, Pascale Sebillon, Marcel M. A. M. Mannens, Arthur A. M. Wilde, Pascale Guicheney

Research output: Contribution to journalArticleAcademicpeer-review

366 Citations (Scopus)

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare arrhythmogenic disorder characterized by syncopal events and sudden cardiac death at a young age during physical stress or emotion, in the absence of structural heart disease. We report the first nonsense mutations in the cardiac calsequestrin gene, CASQ2, in three CPVT families. The three mutations, a nonsense R33X, a splicing 532+1 G>A, and a 1-bp deletion, 62delA, are thought to induce premature stop codons. Two patients who experienced syncopes before the age of 7 years were homozygous carriers, suggesting a complete absence of calsequestrin 2. One patient was heterozygous for the stop codon and experienced syncopes from the age of 11 years. Despite the different mutations, there is little phenotypic variation of CPVT for the CASQ2 mutations. Of the 16 heterozygous carriers of these various mutations, 14 were devoid of clinical symptoms or ECG anomalies, whereas 2 of them had ventricular arrhythmias at ECG on exercise tests. In line with this, the diagnosis of the probands was difficult because of the absence of a positive family history. In conclusion, these additional three CASQ2 CPVT families suggest that CASQ2 mutations are more common than previously thought and produce a severe form of CPVT. The full text of this article is available at http://www.circresaha.org
Original languageEnglish
Pages (from-to)E21-E26
JournalCirculation Research
Volume91
Issue number8
DOIs
Publication statusPublished - 2002

Cite this